6,11-BRIDGED ERYTHROMYCIN DERIVATIVES
    22.
    发明授权
    6,11-BRIDGED ERYTHROMYCIN DERIVATIVES 有权
    6,11-VERBRÜCKTEERYTHROMYCINDERIVATE

    公开(公告)号:EP1027361B1

    公开(公告)日:2003-05-07

    申请号:EP98956314.3

    申请日:1998-10-29

    CPC classification number: C07H17/08

    Abstract: Novel 6,11-bridged erythromycin compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity having formula (I) or (II); compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier; a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention; and processes for their preparation.

    CYCLIC PHOSPHITES AND PHOSPHATES
    23.
    发明公开
    CYCLIC PHOSPHITES AND PHOSPHATES 审中-公开
    循环和磷酸亚磷酸酯

    公开(公告)号:EP1017706A1

    公开(公告)日:2000-07-12

    申请号:EP98947047.1

    申请日:1998-09-15

    CPC classification number: C07H17/08

    Abstract: Disclosed are the antibacterial compounds having formulas (I) or (II) or pharmaceutically acceptable salts and esters thereof. Also disclosed are the processes for preparing compounds of formulas (I), and (II) of the invention, pharmaceutical compositions comprising a therapeutically effective amount of a compound of the invention in combination with pharmaceutically acceptable carrier, as well as a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention.

    MULTICYCLIC ERYTHROMYCIN DERIVATIVES
    24.
    发明公开
    MULTICYCLIC ERYTHROMYCIN DERIVATIVES 失效
    多环红霉素衍生物

    公开(公告)号:EP0984975A1

    公开(公告)日:2000-03-15

    申请号:EP98923678.1

    申请日:1998-05-22

    CPC classification number: C07H17/08 Y02P20/55

    Abstract: Novel multicyclic erythromycin compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity having formulae (I), (II), (III), (IV), (V), (VI), (VII), (VIII), (IX), (X), or (XI), pharmaceutical compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier, as well as a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of formula (I).

    Abstract translation: 具有式(I),(II),(III),(IV),(V),(VI),(VII),(VIII),(IX)的新的具有抗菌活性的多环红霉素化合物及其药学上可接受的盐和酯, ),(X)或(XI)的药物组合物,包含治疗有效量的本发明化合物和药学上可接受的载体的药物组合物,以及通过向哺乳动物施用药物组合物来治疗细菌感染的方法, 治疗有效量的式(I)化合物。

    3-DEOXY-3-DESCLADINOSE DERIVATIVES OF ERYTHROMYCINS A AND B
    25.
    发明公开
    3-DEOXY-3-DESCLADINOSE DERIVATIVES OF ERYTHROMYCINS A AND B 失效
    红霉素A和B的3-脱氧-3-脱氧葡萄糖衍生物

    公开(公告)号:EP0874863A1

    公开(公告)日:1998-11-04

    申请号:EP96940766.0

    申请日:1996-11-06

    CPC classification number: C07H17/08

    Abstract: A compound selected from groups (I), (II), and (III), wherein A, B, V, W, X and R8 are specifically defined; pharmaceutical compositions thereof; a method of treating or preventing bacterial infections by administering therapeutically effective pharmaceutical compositions thereof; and a process for the preparation thereof.

    Abstract translation: 选自组(I),(II)和(III)的化合物,其中A,B,V,W,X和R8具体定义; 其药物组合物; 通过给予其治疗有效的药物组合物治疗或预防细菌感染的方法; 及其制备方法。

    MULTICYCLIC ERYTHROMYCIN DERIVATIVES
    27.
    发明授权
    MULTICYCLIC ERYTHROMYCIN DERIVATIVES 失效
    多克隆抗红霉素

    公开(公告)号:EP0984975B1

    公开(公告)日:2003-04-23

    申请号:EP98923678.1

    申请日:1998-05-22

    CPC classification number: C07H17/08 Y02P20/55

    Abstract: Novel multicyclic erythromycin compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity having formulae (I), (II), (III), (IV), (V), (VI), (VII), (VIII), (IX), (X), or (XI), pharmaceutical compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier, as well as a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of formula (I).

    3-DEOXY-3-DESCLADINOSE DERIVATIVES OF ERYTHROMYCINS A AND B
    28.
    发明授权
    3-DEOXY-3-DESCLADINOSE DERIVATIVES OF ERYTHROMYCINS A AND B 失效
    红霉素A和B的3-脱氧-3-脱氧葡萄糖衍生物

    公开(公告)号:EP0874863B1

    公开(公告)日:2003-01-29

    申请号:EP96940766.7

    申请日:1996-11-06

    CPC classification number: C07H17/08

    Abstract: A compound selected from groups (I), (II), and (III), wherein A, B, V, W, X and R are specifically defined; pharmaceutical compositions thereof; a method of treating or preventing bacterial infections by administering therapeutically effective pharmaceutical compositions thereof; and a process for the preparation thereof.

    Abstract translation: 选自组(I),(II)和(III)的化合物,其中A,B,V,W,X和R8具体定义; 其药物组合物; 通过给予其治疗有效的药物组合物治疗或预防细菌感染的方法; 及其制备方法。

    6,11-BRIDGED ERYTHROMYCIN DERIVATIVES
    29.
    发明公开
    6,11-BRIDGED ERYTHROMYCIN DERIVATIVES 有权
    6,11 - 桥红霉素

    公开(公告)号:EP1027361A1

    公开(公告)日:2000-08-16

    申请号:EP98956314.3

    申请日:1998-10-29

    CPC classification number: C07H17/08

    Abstract: Novel 6,11-bridged erythromycin compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity having formula (I) or (II); compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier; a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention; and processes for their preparation.

Patent Agency Ranking